Companies

Tahoe Therapeutics

tahoebio.ai

Tahoe Bio builds AI models of human cells to accelerate drug discovery using gigascale single-cell data.

HQSan Francisco
Employees11-50
Funding$42M
Valuation$120M
3 active roles
Healthcare AIAI ApplicationB2B SaaSSeries A$10M-$50M

About

Tahoe Bio develops AI-powered models of the human cell to accelerate drug discovery, building gigascale perturbative single-cell datasets and open-sourcing foundational data to train virtual cell models. Its platform targets pharmaceutical and biotech researchers seeking scalable, data-driven drug discovery and precision medicine, monetizing through access to AI datasets and modeling capabilities.

Active Roles

3
South San Francisco/Data & Analytics/152d ago
South San Francisco/Engineering/152d ago
South San Francisco/Other/152d ago

Key Investors

Amplify Partners, Databricks Ventures, Wing Venture Capital, General Catalyst, Civilization Ventures, Conviction Partners, Mubadala Capital Ventures, Overlap Holdings, AIX Ventures